Etodolac and Enlarged heart - a phase IV clinical study of FDA data

Summary:

Enlarged heart is reported as a side effect among people who take Etodolac (etodolac), especially for people who are female, 60+ old, also take Diclofenac Sodium, and have Gastrointestinal mucosal disorder.

The phase IV clinical study analyzes which people have Enlarged heart when taking Etodolac. It is created by eHealthMe based on reports of 8,707 people who have side effects when taking Etodolac from the FDA, and is updated regularly.

What is Etodolac?

Etodolac has active ingredients of etodolac. It is often used in arthritis. eHealthMe is studying from 9,157 Etodolac users. Check the latest studies of Etodolac.

What is Enlarged heart?

Enlarged heart is found to be associated with 1,456 drugs and 1,662 conditions by eHealthMe. Check the latest studies of Enlarged heart.

On Jul, 05, 2026

8,707 people reported to have side effects when taking Etodolac.
Among them, 25 people (0.29%) have Enlarged heart.

Among these 25 people:

What is the gender of people who have Enlarged heart when taking Etodolac? *

female: 52 %
male: 48 %

What is the age of people who have Enlarged heart when taking Etodolac? *

What are other drugs people take besides Etodolac? *

What are other side effects people have besides Enlarged heart? *

Fever: 12 people, 48.00%
Cough: 11 people, 44.00%
Cardiac Failure Congestive: 11 people, 44.00%
Weakness: 9 people, 36.00%
Dyspnea (difficult or laboured breathing): 8 people, 32.00%
Electrocardiogram St Segment Elevation: 8 people, 32.00%
Dizziness: 8 people, 32.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 8 people, 32.00%
Troponin T Increased: 8 people, 32.00%
Acute Myocardial Infarction (acute heart attack): 8 people, 32.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 32.00%
Insomnia (sleeplessness): 8 people, 32.00%
Gastrointestinal Mucosal Disorder (disorder of gastrointestinal lining mucous membranes): 8 people, 32.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 12.00%
Multiple Myeloma (cancer of the plasma cells): 3 people, 12.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 12.00%
Osteoporosis (bones weak and more likely to break): 2 people, 8.00%
Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 1 person, 4.00%
High Blood Pressure: 1 person, 4.00%
High Blood Cholesterol: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Etodolac and have Enlarged heart?

- Check whether Enlarged heart is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Etodolac:

Etodolac (9,157 reports)

Enlarged heart treatments and more:

Enlarged heart (20,022 reports)

Browse all side effects of Etodolac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enlarged heart:

Enlarged heart (1,456 drugs)

Browse all the conditions that are associated with Enlarged heart:

Enlarged heart (1,662 conditions)

Related publications that referenced our studies

Liao KF, Cheng KC, Lin CL, Lai SW, "Etodolac and the risk of acute pancreatitis", BioMedicine, 2017 Jan .
Liao KF, Cheng KC, Lin CL, Lai SW, "Etodolac and the risk of acute pancreatitis", BioMedicine, 2017 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on etodolac (the active ingredients of Etodolac) and Etodolac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.